A METHOD FOR QUANTIFYING BEVACIZUMAB
Brevet
Ce document a été publié dans
2017
Résumé en anglais
The present invention relates to the use of an Internal Standard compound in a method for quantifying Bevacizumab in a sample by mass spectrometry, wherein the said Internal Standard compound is described in the specification.
The present invention relates to the use of an Internal Standard compound in a method for quantifying Bevacizumab in a sample by mass spectrometry, wherein the said Internal Standard compound is described in the specification.< Réduire
N° de brevet
PCT/EP2016/072421Unités de recherche